Biggest News Aggregation in the World
📰 Malignant Hematology Program News

Malignant Hematology Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Malignant Hematology Program. Real-time updates on events, politics, business and more.

AbFero Pharmaceuticals Announces Initiation Of Phase 1 Study For Lead Iron Chelator

AbFero Pharmaceuticals Announces Initiation Of Phase 1 Study For Lead Iron Chelator Study to Examine Safety of SP-420 in MDS and MF News provided by Share this article Share this article BOSTON, Feb. 23, 2021 /PRNewswire/ -- AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, today announced the initiation of a Phase 1 study of its lead iron chelator, SP-420, in myelodysplastic (MDS) and myelofibrosis patients (...
United States United Kingdom Ruben Mesa Elizabeth Bowhay Carnes Thomasx Neenan Raymond Bergeron

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science